Opioid Risk Tool (ORT)
- Introduced by
- Webster, Webster
- Year
- 2005
- Type
- Self-report
- Family
- opioid-risk-assessment
What does it do?
The ORT is a brief, 10-item self-report screening instrument designed to identify patients at elevated risk for opioid misuse, addiction, or aberrant drug-related behaviors prior to initiating opioid therapy.
Developed by Webster and Webster in 2005, it stratifies patients into low, moderate, and high risk categories based on personal and family history of substance abuse, psychiatric comorbidity, and psychosocial factors. The ORT is widely used in pain management and primary care settings to guide shared decision-making and risk mitigation strategies when prescribing opioids.
The intuition behind the method
The ORT operationalizes opioid misuse risk as stemming from multiple biopsychosocial factors, including predisposing conditions (family history of addiction, personal substance abuse history), psychiatric vulnerability (depression, anxiety, bipolar disorder, attention-deficit/hyperactivity disorder), and social risk markers (legal history, social support). The instrument recognizes that opioid misuse exists on a spectrum and that risk is not uniformly distributed; individuals with certain demographic or clinical characteristics are at substantially higher risk for problematic use. By identifying high-risk individuals prior to opioid initiation, clinicians can implement more intensive monitoring, psychosocial intervention, or alternative pain management strategies.
History
The ORT was developed by Webster and colleagues at Legacy Pain Center in Portland, Oregon, and published in Pain Medicine in 2005. The instrument was constructed using retrospective data from opioid-treated chronic pain patients and validated against documented aberrant drug-related behaviors (e.g., multiple emergency department visits, controlled substance diversion, urine drug screen positive for illicit substances). The ORT has been widely adopted in pain management and primary care settings and has been translated into several languages. Subsequent validation studies have confirmed its utility for risk stratification, though limitations in predicting individual-level misuse have also been documented.
When to use it
The ORT is appropriate for use in pain management clinics, primary care practices, emergency departments, and other settings where opioid prescribing decisions are made. It is specifically designed for patients with chronic pain being considered for long-term opioid therapy. The ORT should be administered prior to opioid initiation to inform prescribing decisions and risk mitigation planning. It is less useful in acute pain settings where brief opioid exposure is planned, or in patients with established opioid dependence being transitioned to opioid maintenance therapy.
Limitations and considerations
- Relies on self-report and may be subject to underreporting of sensitive information (substance abuse, legal history) due to social desirability
- Does not assess all relevant risk factors (e.g., concurrent benzodiazepine use, active psychiatric instability) that may influence misuse risk
- Risk categories are based on retrospective validation data and may not generalize equally across diverse demographic or clinical populations
- Does not provide ongoing risk monitoring; risk may change during opioid therapy as new information emerges
Source conditions do not replace independent scientific review or validation by an analysis engine.
Strengths
- Brief, validated screening instrument requiring minimal time and no special equipment or training
- Identifies gender-specific risk factors that may affect opioid misuse vulnerability
- Stratifies risk into clinically meaningful categories that inform monitoring intensity and therapeutic approach
- Demonstrated sensitivity and specificity for predicting aberrant drug-related behaviors in opioid-treated patients
- Widely used in pain management and primary care with substantial clinical utility and acceptance
Applications
- Pre-opioid initiation risk assessment in chronic pain patients to inform shared decision-making about risks and benefits of opioid therapy
- Risk stratification to guide frequency and intensity of monitoring, urine drug screening, and structured follow-up during opioid therapy
- Identification of patients for whom non-opioid or multimodal pain management approaches should be prioritized
- Research studies investigating predictors of opioid misuse, aberrant behaviors, and addiction in pain populations
- Occupational health and workers' compensation settings to assess risk when considering opioid prescriptions for occupational injuries
How it works
How it works
The ORT includes 10 items, though the specific items differ for males and females to reflect gender-specific risk factors. Male ORT items assess history of alcohol abuse, illegal drug use, smoking, age, and psychosocial stressors. Female ORT items assess history of alcohol abuse, illegal drug use, age, depression, and anxiety. Each item is rated with a weighted score reflecting the strength of association with misuse risk; weights range from 1 to 4 points per item. The measure is self-administered and takes approximately 3–5 minutes. No special training is required to administer, though clinician review and discussion of findings with the patient is recommended.
Formula
10 items (5 items for males, 5 items for females) assessing personal and family history of substance abuse, psychological disorders, and social factors related to opioid misuse risk
All item responses are summed to yield a total risk score. Scoring differs by gender: for males, the total range is 0–26; for females, the total range is 0–20. Risk categories are applied based on total score: Low risk (score 0–3 for both genders), Moderate risk (score 4–7 for both genders), and High risk (score ≥8 for both genders). Individuals with missing items or partial completion can be scored using available items, though complete administration is preferred for optimal accuracy.
Formula
Sum weighted item scores. Males: total range 0–26; Females: total range 0–20. Risk categories: Low (males 0–3, females 0–3), Moderate (males 4–7, females 4–7), High (males ≥8, females ≥8).
Lower ORT scores (Low risk category) indicate minimal elevations in opioid misuse risk based on documented personal and family history. Moderate risk scores suggest elevated risk factors warranting increased monitoring, patient education, and structured follow-up during opioid therapy. High risk scores indicate substantial risk for opioid misuse, diversion, or addiction and warrant careful consideration of whether opioid therapy is appropriate, or if initiated, require intensive monitoring (e.g., frequent office visits, urine drug screening, controlled substances agreement, psychiatric or addiction medicine consultation).
Formula
Lower scores indicate lower risk for opioid misuse. Moderate and high scores indicate elevated risk for aberrant drug-related behaviors, diversion, addiction, or nonmedical use when prescribed opioids.
Common pitfalls
- Using ORT score alone to deny opioid therapy; the tool is intended to inform risk mitigation planning, not to exclude patients categorically
- Failing to implement monitoring and risk mitigation strategies even in high-risk patients; structured monitoring and psychosocial support reduce misuse risk substantially
- Assuming a low ORT score indicates no risk for opioid misuse; individual variability and unforeseen circumstances can lead to misuse in low-risk individuals
- Neglecting to reassess risk during opioid therapy; new psychosocial stressors, psychiatric decompensation, or substance abuse may emerge over time
Frequently asked questions
Does a high ORT score mean I will become addicted to opioids?
No. A high ORT score indicates elevated risk based on documented personal and family history, but does not predict addiction with certainty. Many high-risk individuals use opioids appropriately when provided with intensive monitoring, psychosocial support, and structured agreements. Risk mitigation strategies can substantially reduce misuse likelihood.
Can the ORT be used to monitor opioid risk during treatment?
The ORT is designed primarily for pre-treatment risk assessment. During opioid therapy, ongoing clinical assessment (including periodic reassessment of psychosocial factors), urine drug screening, and behavioral monitoring are more appropriate. The ORT can be readministered annually or when significant life changes occur.
What should I do if my ORT score is high?
A high ORT score does not exclude you from opioid therapy, but indicates that intensive monitoring and risk mitigation strategies are needed. Discuss with your physician strategies such as more frequent office visits, urine drug screening, psychiatric or addiction medicine consultation, behavioral contracts, and consideration of alternative pain management approaches.
How accurate is the ORT at predicting opioid misuse?
The ORT has moderate sensitivity and specificity for identifying individuals who engage in aberrant behaviors when prescribed opioids. It is effective at risk stratification but cannot perfectly predict individual behavior. Combined with clinical judgment and ongoing monitoring, it improves outcomes.
Are the ORT scores different for men and women?
Yes. The ORT uses gender-specific items and scoring because males and females have different risk factor profiles. Males are asked about alcohol and drug use; females are asked about depression and anxiety. This improves accuracy of risk assessment in each gender.
Can the ORT be used for patients taking opioids for cancer pain or end-of-life care?
The ORT was developed and validated for chronic non-cancer pain populations. Its applicability to cancer pain or palliative care has not been thoroughly studied; clinical judgment about risk versus benefit is essential in these contexts, as opioid undertreatment risks are also important.
Related methods
Sources
Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432–442.
Open DOI referenceCopied.